Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes

Diabetic Medicine

Volumn 21, Issue 2, 2004, Pages 103-113

  Ben Haroush, A ^b   Yogev, Y ^b   Hod, M ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Epidemiology; Gestational diabetes mellitus; Insulin resistance; Risk factors; Type 2 diabetes

Indexed keywords

INSULIN; METFORMIN; TROGLITAZONE;

CONGENITAL MALFORMATION; COST EFFECTIVENESS ANALYSIS; DIABETES CONTROL; DIABETIC OBESITY; DIAGNOSTIC VALUE; DIETARY INTAKE; DISEASE PREDISPOSITION; DYNAMIC EXERCISE; EARLY DIAGNOSIS; EPIDEMIOLOGICAL DATA; ETHNIC GROUP; FEMALE; HEALTH PROGRAM; HERITABILITY; HIGH RISK PREGNANCY; HOLOPROSENCEPHALY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN TREATMENT; LIMB MALFORMATION; MASS SCREENING; MATERNAL HYPERTENSION; MULTIPLE PREGNANCY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; POPULATION RESEARCH; PREGNANCY DIABETES MELLITUS; PREVALENCE; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SPINE MALFORMATION; URINARY TRACT MALFORMATION;

ABNORMALITIES; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MASS SCREENING; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREGNANCY, MULTIPLE; PREVALENCE; RECURRENCE; RISK FACTORS;

EID: 1242292305     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.00985.x     Document Type: Review

References (91)

1. Ryan EA, O'Sullivan MJ, Skyler JS. Insulin action during pregnancy: studies with the euglycemic clamp technique. Diabetes 1985; 34: 380-389.
2. Catalano PM, Tyzbir ED, Wolfe RR, Calles J, Roman NM, Amini SB et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol 1993; 264: E60-E67.
3. Kuhl C. Insulin secretion and insulin resistance in pregnancy and GDM: implications for diagnosis and management. Diabetes 1991; 40: 18-24.
4. American College of Obstetricians and Gynecologists. Gestational Diabetes, Practice Bulletin no. 30. 2001.
5. King H. Epidemiology of glucose intolerance and gestational dia betes in women of childbearing age. Diabetes Care 1998; 21: B9-B13.
6. Hanna FWF, Peters JR. Screening for gestational diabetes; past, present and future. Diabet Med 2002; 19: 351-358.
7. Kjos SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med 1999; 341: 1749-1756.
8. Hod M, Carrapato M. Diabetes and Pregnancy Update and Guidelines. Working Group on Diabetes and Pregnancy. European Association of Perinatal Medicine, 2002.
9. Nahum GG, Huffaker BJ. Racial differences in oral glucose screening test results: establishing race-specific criteria for abnormality in pregnancy. Obstet Gynecol 1993; 81: 517-522.
10. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057.
11. O'Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964; 13: 278-285.
12. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144: 768-773.
13. Sacks DA, Abu-Fadil S, Greenspoon JS, Fotheringham N. Do the current standards for glucose tolerance testing in pregnancy represent a valid conversion of O'Sullivan's original criteria? Am J Obstet Gynecol 1989; 161: 638-641.
14. Magee MS, Walden CE, Benedetti TJ, Knopp RH. Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity. JAMA 1993; 269: 609-615.
15. Naylor CD, Sermer M, Chen E, Sykora K. Cesarean delivery in relation to birthweight and gestational glucose tolerance: pathophysiology or practice style? JAMA 1996; 275: 1165-1170.
16. Metzger BE, Coustan DM, Organizing Committee. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998; 21: B161-B167.
17. WHO. Diabetes Mellitus. Report of a WHO study group. WHO Technical Report Series, 1985; 727: 7-113.
18. Lind T, Phillips PR. Diabetic Pregnancy Study Group of the European Association for the Study of Diabetes. Influence of pregnancy on the 75-g OGTT: a prospective multicenter study. Diabetes 1991; 40: 8-13.
19. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2000; 23: S77-S79.
20. WHO Consultation. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. WHO/NCD/NCS/99.2. Geneva: World Health Organization, 1999.
21. Nord E, Hanson U, Persson B. Blood glucose limits in the diagnosis of impaired glucose tolerance during pregnancy: relation to morbidity. Acta Obstet Gynecol Scand 1995; 74: 589-593.
22. Schmidt MI, Duncan BB, Reichelt AJ, Branchtein L, Matos MC, Forti ACE et al. Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care 2001; 24: 1151-1155.
23. Pettitt DJ. The 75-g oral glucose tolerance test in pregnancy. Diabetes Care 2001; 24: 1129.
24. Coustan DR. Gestational diabetes. Diabetes in America. In: National Institutes of Diabetes and Digestive and Kidney Diseases, 2nd edn. NIH Publication no. 95-1468. Bethesda, MD: NIDDK, 1995: 703-717.
25. WHO Ad Hoc Diabetes Reporting Group. Diabetes and impaired glucose tolerance in women aged 20-39 years. World Health Stat 1992; 45: 321-327.
26. Dooley SL, Metzger BE, Cho NH. Influence of race on disease prevalence and perinatal outcome in a U.S. population. Diabetes 1991; 40: 25-29.
27. Gunton JE, Hitchman R, McElduff A. Effects of ethnicity on glucose tolerance, insulin resistance and beta cell function in 223 women with an abnormal glucose challenge test during pregnancy. Aust NZ Obstet Gynaecol 2001; 41: 182-186.
28. Franks S, Gilling-Smith C, Waston H. Insulin action in the normal and polycystic ovary. Metab Clin North Am 1999; 28: 361-378.
29. Holte J, Gennarelli G, Wide L, Lithell H, Berne C. High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 1998; 83: 1143-1150.
30. Kousta E, Cela E, Lawrence N, Penny A, Millauer B, White D et al. The prevalence of polycystic ovaries in women with a history of gestational diabetes. Clin Endocrinol (Oxf) 2000; 53: 501-507.
31. Anttila L, Karjala K, Penttila RA, Ruutiainen K, Ekblad U. Polycystic ovaries in women with gestational diabetes. Obstet Gynecol 1998; 92: 13-16.
32. Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 2001; 16: 226-229.
33. Koivunen RM, Juutinen J, Vauhkonen I, Morin-Papunen LC, Ruokonen A, Tapanainen JS. Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes. J Clin Endocrinol Metab 2001; 86: 2591-2599.
34. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999; 22: 141-146.
35. Nestler JE. Should patients with polycystic ovarian syndrome be treated with metformin? Hum Reprod 2002; 17: 1950-1953.
36. Hoskins RE. Zygosity as a risk factor for complications and outcomes of twin pregnancy. Acta Genet Med Gemellol 1995; 44: 11-23.
37. Sivan E, Maman E, Homko CJ, Lipitz S, Cohen S, Schiff E. Impact of fetal reduction on the incidence of gestational diabetes. Obstet Gynecol 2002; 99: 91-94.
38. Schwartz DB, Daoud Y, Zazula P, Goyert G, Bronsteen R, Wright D et al. Gestational diabetes mellitus: metabolic and blood glucose parameters in singleton versus twin pregnancies. Am J Obstet Gynecol 1999; 181: 912-914.
39. Egeland GM, Irgens LM. Is a multiple birth pregnancy a risk factor for gestational diabetes? Am J Obstet Gynecol 2001; 185: 1275-1276.
40. Fitzsimmons BP, Bebbington MW, Fluker MR. Perinatal and neonatal outcomes in multiple gestations: assisted reproduction versus spontaneous conception. Am J Obstet Gynecol 1998; 179: 1162-1167.
41. Henderson CE, Scarpelli S, Larosa D, Divon MY. Assessing the risk of gestational diabetes in twin pregnancies. J Natl Med Assoc 1995; 87: 757-758.
42. MacNeill S, Dodds L, Hamilton DC, Armson BA, Vanden Hof M. Rates and risk factors for recurrence of gestational diabetes. Diabetes Care 2001; 24: 659-662.
43. Major CA, deVeciana M, Weeks J, Morgan MA. Recurrence of gestational diabetes: who is at risk? Am J Obstet Gynecol 1998; 179: 1038-1042.
44. Spong CY, Guillermo L, Kuboshige J, Cabalum T. Recurrence of gestational diabetes mellitus: identification of risk factors. Am J Perinatol 1998; 15: 29-33.
45. Nasrat AA, Augensen K, Abushal M, Shalhoub JT. The outcome of pregnancy following untreated impaired glucose intolerance. Int J Gynecol Obstet 1994; 47: 1-6.
46. Ramtoola S, Home P, Damry H, Husnoo A, Ah-Kion S. Gestational impaired glucose tolerance does not inctease perinatal mortality in a developing country: cohort study. Br Med J 2001; 28: 1025-1026.
47. Moses RG, Calvert D. Pregnancy outcomes in women without gestational diabetes mellitus related to the maternal glucose level. Diabetes Care 1995; 18: 1527-1533.
48. Al-Shawaf T, Moghraby S, Akiel A. Does impaired glucose tolerance imply a risk in pregnancy? Br J Obstet Gynaecol 1988; 95: 1036-1041.
49. Roberts RN, Moohan JM, Foo RL, Harley JM, Traub AI, Hadden DR. Fetal outcome in mothers with impaired glucose tolerance in pregnancy. Diabet Med 1993; 10: 438-443.
50. Tan YY, Yeo GS. Impaired glucose tolerance in pregnancy - is it of consequence? Aust NZ J Obstet Gynaecol 1996; 36: 248-255.
51. Jacobson JD, Cousins L. A population-based study of maternal and perinatal outcome in patients with gestational diabetes. Am J Obstet Gynecol 1989; 161: 981-986.
52. Li DFH, Wong VCW, O'Hoy KMKY. Is treatment needed for mild impairment of glucose tolerance in pregnancy? A randomized controlled trial. Br J Obstet Gynaecol 1987; 94: 851-854.
53. Lao TT, Ho LF. Impaired glucose tolerance and pregnancy outcome in Chinese women with high body mass index. Hum Reprod 2000; 8: 1826-1829.
54. Jensen DM, Damm P, Sorensen B, Molsted-Pedersen L, Westergaard JG, Klebe J et al. Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol 2001; 185: 413-419.
55. Aberg A, Rydhstroem H, Frid A. Impaired glucose tolerance associated with adverse pregnancy outcome: a population-based study in southern Sweden. Am J Obstet Gynecol 2001; 184: 77-83.
56. Mello G, Parretti E, Mecacci F, Lucchetti R, Cianciulli D, Lagazio C et al. Anthropometric characteristics of full-term infants: effects of varying degrees of 'normal' glucose metabolism. J Perinat Med 1997; 25: 197-204.
57. Nahum GG. Correlation between 1-hour 50-gram glucose screening test values in successive pregnancies. Obstet Gynecol 2001; 97: S39-S40.
58. Bartha JL, Martinez-Del-Fresno P, Comino-Delgado R. Gestational diabetes mellitus diagnosed during early pregnancy. Am J Obstet Gynecol 2000; 182: 346-350.
59. Bartha JL, Martinez-del-Fresno P, Comino-Delgado R. Postpartum metabolism and autoantibody markers in women with gestational diabetes mellitus diagnosed in early pregnancy. Am J Obstet Gynecol 2001; 184: 965-970.
60. Schaefer-Graf UM, Buchanan TA, Songster G, Montoro M, Kjos SL. Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 2000; 182: 313-320.
61. Kalter H. The non-teratogenicity of gestational diabetes. Paediatr Perinat Epidemiol 1998; 12: 456-458.
62. Aberg A, Westbom L, Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev 2001; 61: 85-95.
63. Martinez-Frias ML, Bermejo E, Rodriguez-Pinilla E, Prieto L, Frias JL. Epidemiological analysis of outcomes of pregnancy in gestational diabetic mothers. Am J Med Genet 1998; 78: 140-145.
64. Janssen PA, Rothman I, Schwartz SM. Congenital malformations in newborns of women with established and gestational diabetes in Washington State, 1984-91. Paediatr Perinat Epidemiol 1996; 10: 52-63.
65. Mikhail LN, Walker CK, Mittendorf R. Association between maternal obesity and fetal cardiac malformations in African American. J Natl Med Assoc 2002; 94: 695-700.
66. Watkins ML, Botto LD. Maternal prepregnancy weight and congenital heart defects in offspring. Epidemiology 2001; 12: 439-446.
67. Moore LL, Singer MR, Bradlee MI, Rothman KJ, Milunsky A. A prospective study of the risk of congenital defects associated with maternal obesity and diabetes mellitus. Epidemiology 2000; 11: 689-694.
68. Queisser-Luft A, Kieninger-Baum D, Menger H, Stolz G, Schlaefer K, Merz E. Does maternal obesity increase the risk of fetal abnormalities? Analysis of 20 248 newborn infants of the Mainz Birth Register for detecting congenital abnormalities. Ultraschall Med 1998; 19: 40-44.
69. Xiong X, Saunders LD, Wang FL, Demianczuk NN. Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes. Int J Gynaecol Obstet 2001; 75: 221-228.
70. Dukler D, Porath A, Bashiri A, Erez O, Mazor M. Remote prognosis of primiparous women with preeclampsia. Eur J Obstet Gynecol Reprod Biol 2001; 96: 69-74.
71. Solomon CG, Seely EW. Brief review: hypertension in pregnancy: a manifestation of the insulin resistance syndrome? Hypertension 2001; 37: 232-239.
72. Joffe GM, Esterlitz JR, Levine RJ, Clemens JD, Ewell MG, Sibai BM et al. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1998; 179: 1032-1037.
73. Innes KE, Wimsatt JH, McDuffie R. Relative glucose tolerance and subsequent development of hypertension in pregnancy. Obstet Gynecol 2001; 97: 905-910.
74. Damm P, Kuhl C, Buschard K, Jakobsen BK, Svejgaard A, Sodoyez-Goffaux F et al. Prevalence and predictive value of women with islet cell antibodies and insulin autoantibodies in women with gestational diabetes. Diabet Med 1994; 11: 558-563.
75. Catalano PM, Tyzbir ED, Simms EAH. Incidence and significance of islet cell antibodies in women with previous gestational diabetes. Diabetes Care 1990; 113: 478-483.
76. Stoffel M, Bell KL, Blacburn CL. Identification of glucokinase mutations in subjects with gestational diabetes mellitus. Diabetes 1993; 42: 937-940.
77. McLeallan JAS, Barrow BA, Levy JC. Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetes. Diabetologia 1995; 38: 693-698.
78. Harder T, Franke K, Kohlhoff R, Plagemann A. Maternal and paternal family history of diabetes in women with gestational diabetes or insulin-dependent diabetes mellitus type I. Gynecol Obstet Invest 2001; 51: 160-164.
79. Vambergue A, Fajardy I, Bianchi F. Gestational diabetes mellitus and HLA class II (-DQ, -DR) association: The Digest Study. Eur J Immunogenet 1997; 24: 385-394.
80. Ober C, Xiang KS, Thisted RA. Increased risk for gestational diabetes mellitus associated with insulin receptor and insulin-like growth factor II restriction fragment length polymorphisms. Genet Epidemiol 1989; 5: 559-569.
81. Greenberg LR, Moore TR, Murphy H. Gestational diabetes mellitus: antenatal variables as predictors of postpartum glucose intolerance. Obstet Gynecol 1995; 86: 96-101.
82. Bian X, Gao P, Xiong X, Xu H, Qian M, Liu S. Risk factors for development of diabetes mellitus in women with a history of gestational diabetes mellitus. Chin Med J (Engl) 2000; 113: 759-762.
83. Peters RK, Kjos SL, Xiang A, Buchanan TA. Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 1996; 347: 227-230.
84. Damm P. Gestational diabetes mellitus and subsequent development of overt diabetes mellitus. Dan Med Bull 1998; 45: 495-509.
85. Fletcher B, Gulanick M, Lamendola C. Risk factors for type 2 diabetes mellitus. J Cardiovasc Nurs 2002; 16: 17-23.
86. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes. A systematic review. Diabetes Care 2002; 25: 1862-1868.
87. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
88. Knowler WC, Barrett-Conno E, Fowle SE, Hamman RF, Lachin JM, Walker EA. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
89. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J. Protection from type 2 diabetes persists in the TRIPOD cohort eight months after stopping troglitazone. Diabetes 2001; 50: A81.
90. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002; 51: 2796-2803.
91. Dornhorst A, Rossi M. Risk and prevention of type 2 diabetes in women with gestational diabetes. Diabetes Care 1998; 21: B43-B49.